DIMENSIONAL FUND ADVISORS LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$16,000
-50.0%
13,057
-74.3%
0.00%
Q2 2022$32,000
-50.0%
50,832
-9.0%
0.00%
Q1 2022$64,000
-46.2%
55,829
+5.4%
0.00%
Q4 2021$119,000
-47.3%
52,969
-19.8%
0.00%
Q3 2021$226,000
-26.4%
66,069
-35.7%
0.00%
Q2 2021$307,000
-11.3%
102,711
-65.3%
0.00%
Q3 2020$346,000
-57.2%
295,795
-66.9%
0.00%
Q2 2020$808,000
-2.7%
893,321
-9.8%
0.00%
Q1 2020$830,000
-12.7%
990,5850.0%0.00%
Q4 2019$951,000
-13.9%
990,585
-7.5%
0.00%
Q3 2019$1,104,000
-42.8%
1,071,4540.0%0.00%
-100.0%
Q2 2019$1,929,000
-6.0%
1,071,454
-1.8%
0.00%0.0%
Q1 2019$2,052,000
+58.0%
1,091,319
-0.9%
0.00%0.0%
Q4 2018$1,299,000
-55.0%
1,101,085
+3.3%
0.00%0.0%
Q3 2018$2,889,000
+62.2%
1,065,874
+14.3%
0.00%0.0%
Q2 2018$1,781,000
+15.5%
932,370
+27.0%
0.00%0.0%
Q1 2018$1,542,000
+82.3%
734,272
+76.2%
0.00%
Q4 2017$846,000
+599.2%
416,689
+358.1%
0.00%
Q3 2017$121,000
-88.2%
90,953
-86.1%
0.00%
Q2 2017$1,024,000
-35.5%
652,481
+32.7%
0.00%
-100.0%
Q1 2017$1,588,000
-23.9%
491,667
+99.0%
0.00%0.0%
Q3 2015$2,088,000
-50.6%
247,069
-36.0%
0.00%
-66.7%
Q2 2015$4,225,000
-22.6%
385,937
-1.2%
0.00%0.0%
Q1 2015$5,462,000
-17.2%
390,6500.0%0.00%
-25.0%
Q4 2014$6,598,000
+25.8%
390,6500.0%0.00%0.0%
Q3 2014$5,243,000
+1.4%
390,650
-3.7%
0.00%0.0%
Q2 2014$5,169,000
+16.2%
405,708
+8.4%
0.00%
+33.3%
Q1 2014$4,449,000
-14.7%
374,135
-1.0%
0.00%
-25.0%
Q4 2013$5,217,000
-22.8%
377,773
-2.5%
0.00%
-33.3%
Q3 2013$6,759,000
-17.7%
387,339
-23.4%
0.01%
-25.0%
Q2 2013$8,217,000505,6310.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders